Search details
1.
Targeting of intracellular oncoproteins with peptide-centric CARs.
Nature
; 623(7988): 820-827, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37938771
2.
Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs.
Nature
; 599(7885): 477-484, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34732890
3.
Retraction Note: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs.
Nature
; 623(7988): 872, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37938785
4.
Synthesis and evaluation of esterified Hsp70 agonists in cellular models of protein aggregation and folding.
Bioorg Med Chem
; 27(1): 79-91, 2019 01 01.
Article
in English
| MEDLINE | ID: mdl-30528127
5.
Design principles to tailor Hsp104 therapeutics.
bioRxiv
; 2024 Apr 28.
Article
in English
| MEDLINE | ID: mdl-38712168
6.
BPTF cooperates with MYCN and MYC to link neuroblastoma cell cycle control to epigenetic cellular states.
bioRxiv
; 2024 Feb 12.
Article
in English
| MEDLINE | ID: mdl-38405949
7.
Evaluation of the DLL3-targeting antibody-drug conjugate rovalpituzumab tesirine in preclinical models of neuroblastoma.
Cancer Res Commun
; 2(7): 616-623, 2022 07.
Article
in English
| MEDLINE | ID: mdl-36381237
8.
The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models.
Clin Cancer Res
; 27(10): 2938-2946, 2021 05 15.
Article
in English
| MEDLINE | ID: mdl-33619171
9.
Epigenomic profiling of neuroblastoma cell lines.
Sci Data
; 7(1): 116, 2020 04 14.
Article
in English
| MEDLINE | ID: mdl-32286315
10.
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design.
Cell Rep
; 29(6): 1675-1689.e9, 2019 11 05.
Article
in English
| MEDLINE | ID: mdl-31693904
11.
Ratchet-like polypeptide translocation mechanism of the AAA+ disaggregase Hsp104.
Science
; 357(6348): 273-279, 2017 07 21.
Article
in English
| MEDLINE | ID: mdl-28619716
12.
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma.
Cancer Cell
; 32(3): 295-309.e12, 2017 09 11.
Article
in English
| MEDLINE | ID: mdl-28898695
Results
1 -
12
de 12
1
Next >
>>